Summary: Net Altas speaks with leading psychedelic researchers to get a pulse on what the next decade may have in store for psychedelic research and medicine. “With both MDMA and psilocybin on the precipice of approvals as mainstream medicines, and several leading universities opening dedicated psychedelic research facilities, the story of the last 10 years has been one of profound breakthroughs. So, as we stand on the precipice of a new decade, it’s worth pausing for a moment and looking forward to investigate what the 2020s may hold in this rapidly accelerating field,” explains Net Altas.
Originally appearing here.
